POSITION STATEMENTS

Perspectives from IPAC On CFC-Free Metered Dose Inhalers (MDIs)
​

IPAC celebrates with the Montreal Protocol Parties on the 30th Anniversary of playing a critical role in caring for human health and the environment and their unwavering continued commitment to the planet.

IPAC-RS was formed as part of the International Pharmaceutical Aerosol Consortium (IPAC) in 1999 and established in 2001 as a separate Consortium, with the mission to enhance the quality and availability to patients of orally inhaled and nasal drug products (OINDP) through scientifically driven advancements related to development and regulation of these products.

IPAC Secretariat

1500 K Street, NW

Suite 1100

Washington, DC  20005

USA